MODERATE-TO-SEVERE ASTHMA
Clinical trials for MODERATE-TO-SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis Phase 3 trial tests an injectable drug called CM326 in 230 adults with moderate to severe asthma. The goal is to see if it can reduce the number of severe asthma attacks over one year. Participants will receive either CM326 or a placebo, and researchers will also measure cha…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New program helps doctors prescribe better asthma treatment
Disease control Recruiting nowThis study tests a program to help doctors at community health centers prescribe a recommended asthma treatment called SMART (Single Maintenance and Reliever Therapy). The program includes training, feedback, and educational tools for both doctors and patients. Researchers will m…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE4 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC